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A b s t r a c t
Obective: To test the hypothesis that the clusters of senile plaques (SP) and neurofibrillary tangles (NFT) in patients
with Alzheimer's disease (AD) are spatially associated as predicted by the 'Amyloid Cascade Hypothesis'. 
Methods: The spatial association between the SP and NFT was studied in the cerebral cortex and hippocampus in
six cases of sporadic Alzheimer's disease (AD) using contingency tables. The coefficient C7 was used as an index of
spatial association while chi-square with correction for continuity was used as a test of significance. 
Results: In the brain regions analysed, values of C7 were in the range -0.31 to +0.32 but a statistically significant
spatial association between SP and NFT was present in only 8/39 (21%) regions. The degree of spatial association
between the SP and NFT was similar in different brain regions and did not vary with apolipoprotein ε genotype of
the patient. However, the magnitude of C7 in a region was positively correlated with the density of the NFT and with
the total density of SP and NFT but not with the density of SP alone. 
Conclusion: There was little evidence that SP and NFT were spatially associated except in brain areas with high
densities of lesions. The data support the hypothesis that SP and NFT are distributed relatively independently in the
cerebral cortex and hippocampus and therefore, could be distinct phenomena in AD. 
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Introduction
Alzheimer's disease (AD) is characterised by the
presence of two hallmark lesions in the brain, viz.,
senile plaques (SP) and neurofibrillary tangles (NFT).
The most important constituent of the SP is the protein
amyloid-β (Aβ) [15]. Aβ is an approximately 4-kDa
peptide arising by cleavage of a larger
trans-membrane amyloid precursor protein (APP)
present in most brain cells. The Aβ peptide exists in
alternative spliced forms, the most common being
Aβ42/43 found predominantly in SP and the more
soluble Aβ40 found in association with blood vessels
[23]. Deposition of Aβ in familial [10] and sporadic AD
[30] is probably the result of processes that increase
the proportion of the highly amyloidogenic peptide
Aβ42/43 [16]. By contrast, NFT are intracellular
inclusions composed of paired helical filaments
(PHF), the most important molecular constituent of
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which is the microtubule protein tau. There is a single
gene for tau and different isoforms result from
alternative splicing and post-transcriptional changes
[13]. In AD, all six isoforms of tau are abnormally
phosphorylated and aggregated into PHF [9]. 
The 'Amyloid Cascade Hypothesis (ACH) ' [17] is the
most important theory to date to explain the
pathology of AD. This hypothesis proposes that there
is a direct causal relationship between the
pathogenesis of the SP and NFT, viz., the deposition of
Aβ is the initial pathological event in AD leading to the
formation of NFT, neuronal loss, and the development
of dementia [17]. Despite attempts to relate the
development of abnormal tau to Aβ [31], little
evidence has been found that directly connects the
two pathologies [6] suggesting that the processes
leading to the formation of SP and NFT could be
distinct phenomena [11]. Previous studies [6,7] have
concluded that in the cerebral cortex in AD, SP and
NFT are distributed in clusters that often exhibit
a regular distribution parallel to the pia mater. If Aβ
deposition leads to tau pathology as proposed by the
ACH, then the clusters of SP and NFT should not be
randomly distributed with reference to each other but
exhibit a degree of spatial association. To test this
hypothesis, the degree of spatial correlation between
the SP and NFT was measured in various brain
regions in cases of sporadic AD using a statistical
method based on contingency tables. 
Materials and methods 
Cases 
Six cases of sporadic AD, without evidence of
a family history of the disease, were obtained from
the Brain Bank, Dept. of Neuropathology, Institute of
Psychiatry, King's College, London, UK. Informed
consent was given for the removal of all brain tissue
and followed the principles embodied in the 1964
Helsinki declaration. Patients (details in Table I) were
clinically assessed and all fulfilled the 'National
Institute of Neurological and Communicative
Disorders and Stroke and the Alzheimer Disease and
Related Disorders Association' (NINCDS/ADRDA)
criteria for probable AD [32]. The histological
diagnosis of AD was confirmed by the presence of
widespread neocortical SP consistent with the
'Consortium to Establish a Registry of Alzheimer
Disease' (CERAD) criteria [24]. All cases also had
numerous NFT in the cerebral cortex and
hippocampus. Apolipoprotein ε (apo ε) genotype is
a significant risk factor for sporadic AD [28],
individuals with allele ε4 having an increased risk of
developing the disease. In the present study, four of
the cases had an apo ε genotype of 3/4, one case
was 3/3, and the remaining case 2/3. 
Histological methods 
Tissue blocks of the frontal cortex (B8) at the
level of the genu of the corpus callosum, parietal
cortex (B7) at the level of the splenium of the
corpus callosum, occipital cortex including the
calcarine sulcus (B17), superior temporal gyrus
(B38), lateral occipitotemporal gyrus (B36),
parahippocampal gyrus (B28), and hippocampus
were taken from each case. Tissue was fixed in 10%
phosphate buffered formal saline, embedded in
paraffin wax, and 7 µm coronal sections were cut
and stained with the Gallyas silver impregnation
method [14] to reveal the SP and NFT. 
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Case Sex Age (yrs) Onset (yrs) PM delay (months) Apo ε Cause of death
A F 70 64 24 3/4 Brochopneumonia
B F 66 59 – 3/4 Brochopneumonia
C M 73 66 24 2/3 Brochopneumonia
D F 88 – 16 3/3 Brochopneumonia
E M 82 78 11 3/4 Brochopneumonia
F F 87 82 27 3/4 Myocardial infarction
Table I. Details of Alzheimer's disease cases used in the study 
Abbreviations: M = male, F = female, PM = Postmortem, Apo ε = Apolipoprotein ε genotype, – data not available
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Spatial association using contingency tables
Morphometric methods
In the cerebral cortex, a sample of between 64 and
128, 500x500 µm microscopic fields were located at
random throughout the cortical ribbon in each brain
area studied. Sample fields must not be so small that
they are incapable of containing at least two
individuals of the histological features under study.
Conversely, fields should not be too large so that
individuals of the two features occur in every field.
Consideration of the densities, distribution and range
of sizes of lesions suggested that a 500x500 µm field
would be optimal for sampling the SP and NFT. The
presence or absence of SP and NFT was recorded
within each sample field. A lesion was recorded in
a sample field when at least 50% of its area was
present within the field. In the hippocampus, sample
fields were located at random in the pyramidal cell
layer and included sectors CA1 to CA4. 
Statistical methods
In each brain region, the frequencies of the SP and
NFT in all sample fields were first summarised as
a 2x2 contingency table (Table II). From these
frequencies, a 'coefficient of association' (C7) can be
calculated which varies from +1, when the maximum
possible co-occurrence is present, to -1 the minimum
possible co-occurrence [18]. Values close to zero
indicate that the frequencies of the two features are
close to those that would be expected to occur by
chance. The calculation of C7 depends on the
relationships between the numerical values in the
contingency table and is dependent on first, whether
the product of the joint presences and joint absences
(ad) is greater or less than the product of samples
which contain one feature alone (cb) and second, on
the relative magnitude of 'c' and 'b' and 'a' and 'd' (see
Table II) [27]. In addition to C7, a value of chi-square
(χ2) can be calculated from the frequencies in the
contingency table. Chi-square is a test of the null
hypothesis that the two histological features are
distributed independently. Since the χ2 distribution is
continuous and is being used to approximate
a discrete distribution, it is necessary to make
a 'correction for continuity' [26] and this statistic is
given the symbol X2. Differences in the degree of
association between brain regions were tested using
a one-way analysis of variance (ANOVA). Differences
between cases with apo ε genotype 3/4 and those of
genotype 2/3 and 3/3 were tested using Student's 't'
test. The relationship between C7 and the density of
lesions in a brain region was tested using correlation
and regression methods. 
Results
The frequencies of SP and NFT in 104 randomly
located sample fields in a single brain region (Case
A, Superior temporal gyrus) are shown in Table III. In
43/104 fields, either both SP and NFT occur in the
same field (35/104) or both lesions were absent
(8/104). By contrast, there were 61/104 fields in
which either SP or NFT were recorded alone. From
these data, a value of C7 of -0.27 was obtained
indicating a weak but negative spatial association
between the SP and NFT, i.e., there was a greater
tendency for the SP and NFT to occur alone rather
than together in a sample field. The value of χ2
(χ2=1.51) calculated from these data was not
significant suggesting that there was no statistically
significant degree of association between the SP
and NFT, i.e., essentially the SP and NFT are
distributed independently in this region. 
The values of C7 and χ
2 obtained from all brain
regions and cases investigated are summarised in
Table IV. The value of C7 varied from -0.31 to +0.32
suggesting weak spatial associations but significant
values of χ2 were observed in only 8/39 (21%) of the
SP 
present absent
NFT present a b
absent c d
When ad≥bc and c<b C7=ad–bc/(a+b) (b+d) 
When ad≥bc and c≥b C7=ad–bc/(a+c) (c+d) 
When ad<bc and a≥d C7=ad–bc/(a+b) (a+c) 
When ad<bc and a>d C7=ad–bc/(b+d) (c+d) 
χ2=[|ad–bc|–N/2]2N/(a+b) (c+d) (a+c) (b+d) 
Table II. The 2x2 contingency table method for
measuring the degree of spatial association
between senile plaques (SP) and neurofibrillary
tangles (NFT) in Alzheimer's disease (AD)
showing the calculation of the index of
association C7 and chi-square with correction
for continuity (χ2) 
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brain areas studied. In all regions where there was
a significant degree of association between the SP
and NFT, the two lesions were positively associated.
There was no significant difference in the
magnitude of C7 between brain regions (F=1.06,
P>0.05) or between patients with different apo ε
genotypes (t=0.54, P>0.05). However, the value of C7
was positively correlated with the overall density of
NFT (r=0.36, P<0.05) and with the total density of
lesions (SP+NFT) (r=0.44, P<0.01) (Fig. 1) but not
with SP alone (r=0.27, P>0.05). 
Discussion
A significant spatial association between the SP
and NFT was found in approximately 20% of the
brain areas studied consistent with previous studies
[6,19]. A number of hypotheses could explain the lack
of spatial association in the majority of brain areas.
First, the degree of association is dependent on field
size [26] and the sample field may have been too
small to have a significant chance of including both
lesions. However, considering the densities, sizes,
and distribution of lesions, the field size used was
large enough to sample both the SP and NFT
adequately. Second, the degree of association
between SP and NFT could depend on the stage of
the disease. For example, early in the disease
process, the SP and NFT may be present in small
co-localised clusters [6,7] but later, the correlation
may disappear if one of the lesions becomes more
abundant and widely distributed than the other. In
the present study, however, both lesions become
widely distributed and the degree of association
between the SP and NFT becomes greater as their
density increases. Third, the Gallyas stain may
preferentially stain the primitive and classic subtypes
of SP but not the diffuse SP [2,3]. Hence, a more
significant association between the SP and NFT may
be detected using methods that stain all the SP in
the tissue [5]. The Gallyas-stained SP, however,
contain tau positive PHF and are likely to be the most
closely related population of plaques to the cellular
NFT [8]. Fourth, SP and NFT may not be spatially
associated within the same area of the cortex but
there could be a more complex relationship between
the two lesions, e.g., SP may develop on the axon
terminals of NFT containing neurons [8,12,22,25,29]. 
The degree of association between SP and NFT (C7)
in a region was positively correlated with NFT density
and with the total density of both lesions but not with
the density of SP alone. These results suggest that the
probability of observing a spatial association between
the SP and NFT is more likely in areas with larger
numbers of lesions. Two histological features may
appear to be positively associated if large numbers of
lesions are present if there are some areas of the
section that are 'unsuitable' for the development of
either feature. In such a circumstance, the number of
empty plots ('d' in a 2x2 table) may be large leading to
a spurious positive association. This could arise in the
present study during random sampling across the
cerebral cortex as SP and NFT may occur with greater
abundance in laminae II/III and V/VI respectively and
are not randomly distributed across the section [4]. In
SP
present absent total
NFT present 35 49 84




Table III. Frequencies of senile plaques (SP) and
neurofibrillary tangles (NFT) in 104 randomly
located sample fields in the superior temporal
gyrus of a case of Alzheimer's disease (Case A) 
Fig. 1. Correlation between the degree of
association (C7) and the total density of senile
plaques (SP) and neurofibrillary tangles (NFT) in
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addition, a positive association can arise if both
histological features studied are common and
distributed in patches throughout the entire area. If
the patches are large relative to the total area sampled
(a 'coarse grained' pattern) [1], then there may be
a considerable area of overlap between the two
features that is largely due to chance. In such areas, it
may be possible to record sufficient sample fields with
both SP and NFT to achieve a significant χ2. Consistent
with this hypothesis, large scale clustering of SP [6]
and NFT [2] is often observed in the cerebral cortex in
AD. A similar hypothesis has been proposed to explain
the positive spatial associations observed between SP
and blood vessels in AD [20,21], viz., when SP are
especially abundant, there is a high probability that
a sufficient proportion of them will contact a blood
vessel profile by chance. 
In conclusion, the data suggest that clusters of SP
and NFT are not spatially associated in the majority of
areas of the cerebral cortex and hippocampus studied
in cases of sporadic AD. Where positive associations
are present, they are likely to be attributable to the
abundance and wide distribution of the lesions in the
tissue rather than reflect a causal relationship
between them. Hence, it is unlikely that the formation
of SP and NFT occurs in relation to either the same or
closely related cell bodies as predicted by the 'amyloid
cascade hypothesis'. The data therefore support the
hypothesis that Aβ and tau pathology are discreet
phenomena in AD [6,11]. 
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